MedTech Innovator Appoints Former FDA Official Dr. Jeffrey Shuren as Advisor
Photo Credit: Jeffrey Shuren, Advisor, MedTech Innovator • Photo Credit: MedTech Innovator
Corporate Business News Sponsored by Business Watch Global
LOS ANGELES, June 18, 2026, (VSNewsNetwork.com) — Medical technology accelerator MedTech Innovator, has announced the appointment of Dr. Jeffrey Shuren as an advisor.
Shuren will provide strategic guidance on regulatory strategy, policy developments, and global market access for the organization, its accelerator programs, and portfolio companies.
Shuren previously served as Director of the U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH). During his tenure, he oversaw initiatives including the Breakthrough Devices Program, the Patient Engagement Program, the Digital Health Center for Excellence, the Total Product Life Cycle Advisory Program (TAP), and Home as a Healthcare Hub.
@VSNewsNetwork
•
@VSNewsNetwork •
Shuren brings more than two decades of leadership experience from the FDA and the Centers for Medicare and Medicaid Services.
“Jeff’s leadership at FDA transformed how medical technologies are evaluated and brought to market. His experience accelerating innovation while maintaining rigorous patient safety standards will be invaluable to our portfolio companies to help avoid costly delays and increase the chance of success as they advance innovative solutions to benefit patients,” said Paul Grand, Founder and CEO of MedTech Innovator.
According to the company, Shuren will help early- and mid-stage medical technology companies navigate regulatory requirements and market access challenges as they develop new healthcare products.
“MedTech Innovator plays a critical role in supporting the next generation of medical technology leaders. I’m excited to contribute to an organization that helps entrepreneurs translate transformative ideas into solutions that improve the health and quality of life of people globally,” said Dr. Jeffrey Shuren.
MedTech Innovator has reviewed more than 20,000 applicants since its founding and supported 838 companies through its accelerator programs. According to the company, participating startups have collectively raised $12 billion in follow-on funding, completed 63 acquisitions, and brought more than 500 products to market.
For more information, visit www.medtechinnovator.org.
Source: MedTech Innovator
